Patents by Inventor Zeljko Zupanovic

Zeljko Zupanovic has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Thienodibenzoazulene compounds as tumor necrosis factor inhibitors
    Publication number: 20050171091
    Abstract: The present invention relates to the dibenzoazulene compounds represented by formula I as well as to their pharmaceutical preparations for the inhibition of tumor necrosis factor alpha (TNF-?) and interleukine 1 (IL-1) in mammals at all diseases and conditions where these mediators are excessively secreted. The compounds of the present invention also demonstrate an analgetic action and can be used to relieve pain.
    Type: Application
    Filed: March 25, 2005
    Publication date: August 4, 2005
    Applicant: Pliva d.d.
    Inventors: Mladen Mercep, Milan Mesic, Dijana Pesic, Zeljko Zupanovic, Boska Hrvacic
  • Thienodibenzoazulene compounds as tumor necrosis factor inhibitors
    Patent number: 6897211
    Abstract: The present invention relates to the dibenzoazulene compounds represented by formula I as well as to their pharmaceutical preparations for the inhibition of tumor necrosis factor alpha (TNF-?) and interleukine 1 (IL-1) in mammals at all diseases and conditions where these mediators are excessively secreted. The compounds of the present invention also demonstrate an analgetic action and can be used to relieve pain.
    Type: Grant
    Filed: November 18, 2002
    Date of Patent: May 24, 2005
    Assignee: Pliva-Istrazivacki Institut d.o.o.
    Inventors: Mladen Mercep, Milan Mesic, Dijana Pesic, Zeljko Zupanovic, Boska Hrvacic
  • Thienodibenzoazulene compounds as tumor necrosis factor inhibitors
    Publication number: 20030153750
    Abstract: The present invention relates to the dibenzoazulene compounds represented by formula I as well as to their pharmaceutical preparations for the inhibition of tumor necrosis factor alpha (TNF-&agr;) and interleukine 1 (IL-1) in mammals at all diseases and conditions where these mediators are excessively secreted. The compounds of the present invention also demonstrate an analgetic action and can be used to relieve pain.
    Type: Application
    Filed: November 18, 2002
    Publication date: August 14, 2003
    Applicant: Pliva farmaceutska industrija, dionicko drustvo
    Inventors: Mladen Mercep, Milan Mesic, Dijana Pesic, Zeljko Zupanovic, Boska Hrvacic